Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type

Author： Ulbrich H. Fiebich B. Dannhardt G.

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.37, Iss.12, 2002-12, pp. : 953-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

By Charlier C. Michaux C.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 645-659

Elsevier

Access to resources Recommend Favorite

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

By de Gaetano G. Donati M.B. Cerletti C.

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Recent Development in the Field of Dual COX / 5-LOX Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 633-638

Bentham Science Publishers

Access to resources Recommend Favorite

New Trends in Dual 5-LOX / COX Inhibition

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 941-962

Bentham Science Publishers

Access to resources Recommend Favorite